WAT · NYSE · Medical - Diagnostics & Research

Waters (WAT)

Supplies analytical instruments, diagnostics, consumables, and service for regulated laboratory workflows.

$426.09
vs last close+0.35 (+0.08%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Apr 2026Q2 FY26Jul 2026
Revenue7128196377097408736627718009321,2671,645
Cost of revenue291318262288302349277321328375672911
Gross profit420501375420439524385450472557595734
241237241231228232233262280247642820
Research & development4244454645474749545096122
187180175173169173175201214197394405
General & administrative00000000214000
Other expenses1212221213121212120152293
Operating income179264134189211292152188192311−47−86
−26−27−19−20−18−15−9−11−22−46−41−55
Interest income454445455060
Interest expense30312624211914142794855
Other non-operating income−4−4−7−4−4−4−5−4−538−10
Income before tax153238115169194277143178170264−88−141
Income tax expense19211327324622312139−16−5
Net income from continuing operations135216102143162231121147149225−72−136
Net income135216102143162231121147149225−72−136
EPS, basic$2.28$3.66$1.73$2.41$2.72$3.90$2.04$2.47$2.50$3.78−$0.87−$1.39
EPS, diluted$2.27$3.65$1.72$2.40$2.71$3.88$2.03$2.47$2.50$3.77−$0.87−$1.39
Weighted average shares, basic595959595959596060608298
Weighted average shares, diluted595959596060606060608298
EBITDA231316189240263345207244249325106215
Depreciation & amortization48484947484949525353152301
EBIT184268140193215296157192197273−46−86